Member Info for Trisor

UG that’s not entirely true I’m afraid. There was an imminent deal in the farming space Successful meetings tweets, discussions linked to oval x money. Clear insinuation there that a final cash injection was needed to close. Not for business lunches to talk. Thought it was professional fees payment related myself. The GB Nanoshop and products.

There’s ip , the ink and there are products. There’s the disc equipment. Worth I don’t know. We haven’t seen accounts so don’t know what the assets are.

nanosynth group plc, the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, announces that Richard Clarke has today resigned from the Company to pursue other business interests with such resignation becoming effective on 7 April 2023. Richard will remain as Chairman until then or upon an appropriate replacement being appointed if sooner. The Board has commenced a process to identify a suitable candidate and further announcements will be made in due course

Castle Richard Clarke was gone and we were told that he would stay on until a new chairman was appointed giving the impression that the search was and an appointment would be made or April 7 whichever was the later. Macnamara also left apparently . So they’ve been cutting costs whilst trying to imply all fine and just normal business process.

The only guy left with m & a experience is Peter Gray I believe.

Castle he has left as of April 7 th I believe

This is the key statement. If you get things under control and it’s sustainable , then you tell us about catalysts, super exciting opportunities, imminent deals to occur (farming agreement) , tweet about products etc. update websites and then you lay on a 7 weeks to go before potential lights out post having had an opportunity to tell us in January that the finances weren’t great and make out that the oval x deal was to progress deals.

And the above is all absolutely acceptable is it and in line with Aim rules?

“The Interim results include non-recurring charges as a result of action taken to reduce overhead cost. The Board has now completed its review as of September 22 and now believes that, as a result of these actions, the cash burn has been reduced to a sustainable level”

Castle what is the meaning of your post

From the half year Financial Overview report. Last paragraph on sustainability

During the six months to 30 June 2022, the Group recorded revenues from continuing operations of £9,988 compared with £133,116 for the six months to 30 June 2021. The operating loss from continuing operations for the period was £1,781,217 (30 June 2021: £1,162,718). The loss per share on continuing operations was 0.085 pence (30 June 2021: loss per share 0.057 pence).



? Consolidated net assets at 30 June 2022 amounted to £3,443,023 (31 December 2021: £4,959,667).

? Cash balances at the period end amounted to £1,787,242 (31 December 2021: £3,760,992).



The Interim results include non-recurring charges as a result of action taken to reduce overhead cost. The Board has now completed its review as of September 22 and now believes that, as a result of these actions, the cash burn has been reduced to a sustainable level.

10th January 2023



nanosynth group plc

("nanosynth" or the "Company" or the "Group")

Placing and Subscription to raise £0.4 million

nanosynth group plc, the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, is pleased to announce a conditional placing to raise gross proceeds of £0.4 million (the "Placing") through the issue of 222,222,222 new ordinary shares of 0.01 pence each in the Company ("Ordinary Shares") at a price of 0.18 pence per Ordinary Share (the "Placing Shares").

The issue of the Placing Shares is within the Company's existing allotment authorities. The Placing Shares equate to approximately 8.4% of the Company's currently issued share capital. In addition, participants in the Placing have been issued with one warrant for every two Placing Shares exercisable at 0.5p pence per share at any time up to two years from Admission, as defined below.

The funds raised from the Placing will be principally used for working capital purposes and to accelerate the Company's near-term commercial opportunities.

Mark Duffin, CEO of nanosynth, commented: "I am pleased that we are able to raise money to further our commercial objectives. We are receiving considerable interest from major household brands for our nanoparticle technology and these funds will enable the Company to advance the progress of these discussions. We look forward to updating the market on these developments shortly

30th September 2022

nanosynth group plc

("nanosynth", the "Company" or the "Group")



Half Yearly Report to 30 June 2022



nanosynth group plc, the AIM quoted company specialising in the synthesis and application of nanoparticles to create new and improve existing products, is pleased to present its unaudited half yearly report for the six-month period ended 30 June 2022.



Operational highlights for the period:



· Successful trial results with Volz Holdings and REACH UK registration

o Creating potential to lead to wider adoption by the global filtration industry

o Pipeline of interest is already at an advanced stage

· Joint development agreement with a global wellness company for their first project in the cosmetics market

o On successful completion, opportunity to enter into an exclusive commercial agreement for the supply of nanoparticles for this cosmetics market

· New share subscription agreement to raise £2,942,500

o Proceeds to be used primarily to fund its working capital requirements as the Group looks to commercialise its bespoke nanoparticle technology

· Directors continue to purchase shares in the Company

o Confidence in considerable potential of the Group's nanoparticle technology

· Strengthened Board

o New board members enhance commercial expertise and corporate governance



Mark Duffin, Chief Executive Officer commented:

"We are pleased with the recent updates that we have been able to share as a result of the hard work especially during the last 12 months. The REACH UK registration will allow our partner Volz to apply antiviral technology to all their products. This has the potential to lead to wider adoption by the global filtration industry. The first project in our R&D programme that was secured is a testimony to our leadership in the nanotechnology market. Confidentiality and competitive advantage remain our priority during the development stage and we look forward to potentially becoming exclusive partners in the future. The funding arrangements with Lanstead provide further working capital as the Group looks to commercialise its bespoke nanoparticle technology.



"As a result, we are very excited about the future of the business and are confident about the near term prospects of the business."

That’s actually not correct. They had plenty of capital to play with.

Thank you EXMS- that is exactly the point I’m making . I can assure you if this goes belly up , I’ll be speaking to a lawyer about my rights and getting in touch with the FCA.

UG - we were told the LA was good for shareholders because of certain catalysts? What were these catalysts and why have they not materialised. In the recent RNS a deal was imminent. And finally there is no mention anywhere that the company had serious cash issues before now. We had 3.7 as at December 21. There was a cash burn which was stated as now being sustainable as at September 22. If it was sustainable why on god’s earth are we told with seven weeks to go that it’s nearly lights out folks.

Sustainable means cutting your cloth accordingly. Why weren’t we told in the Jan rns about the seriousness of the situation. There’s money I wouldn’t have invested. And finally directors of aim company have duties to keep their shareholders informed. I can’t recall the rule but it’s actually on the website. There’s plenty here unanswered

They may well do EXMS. But when ? They have about 375 m shares left.

Ex MS at this price is it worth it? I do think they might sell some next week.

Kg16 I don’t know how this would be possible. Even if there was a consolidation (no idea how this would work) then who will buy. It needs to be accompanied with a significant order in tow.

Sinden my faith is really shaken here. Don’t trust anyone on this board (sorry no disrespect) , am totally astounded that we get a January RNS and then a 7 weeks to go RNS. What options are being evaluated? How close are we to income? Neither mentioned, so I can’t really trust what I’m being told by no one . It is without doubt a pickle . I’m not a trader. No idea when the best time to buy in and seek to make back losses. So basically I’m in a quandry. Just went to church. I renounced satan but other than that got no clear tips from the big guy. Perhaps eating a cream egg might sort things out. I’ll give it a go.

Sinden I have no idea what to do. Everyone has to make their own mind up. From the RNS it sounds that options are on the table being evaluated. Seriously this has become a lottery. I urge all to think very carefully before doing what they do as it could have significant repercussions. GLA and happy easter

A long term loan is difficult but not impossible. This will depend on if there is any commercial revenue ready to pop. Plenty of start ups get loans if they have a decent business plan and products ready to go

Only realistic plan is a very big placing or an RTO.

I’m still genuinely flabbergasted as to how it’s got to 7 weeks money left from we are pleased to advise you of the investments of Lansted and Oval X and the positive RNS

Cave completely quiet. Not a peep. Is he happy for this to disappear to the depths of the ocean? Time these people stepped up to the plate and put some money in themselves

Hi Callit - unless they start again. But yes your sentiment is something I share